...
首页> 外文期刊>Medicine. >Could ADC values be a promising diagnostic criterion for differentiating malignant and benign hepatic lesions in Asian populations: A meta-analysis
【24h】

Could ADC values be a promising diagnostic criterion for differentiating malignant and benign hepatic lesions in Asian populations: A meta-analysis

机译:ADC值是否可以成为鉴别亚洲人群恶性和良性肝病变的有前途的诊断标准:一项荟萃分析

获取原文

摘要

Background: Liver cancer exhibits geographic and ethnic differences in its prevalence and biology, which implies that it is impractical to develop universal guidelines for all patients. Thus, a meta-analysis was conducted to identify the accuracy of apparent diffusion coefficients (ADCs) for discriminating malignant from benign liver lesions in Asians. Methods: Eligible studies published in PubMed, Ovid, and Embase/Medline were updated onto October 2014. STATA 12.0 and Meta-Disc 1.4 were used to perform this meta-analysis. Results: Eight studies comprising 661 benign liver lesions and 598 malignant liver lesions fulfilled all the inclusion criteria. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.88 (95% confidence interval [CI] 0.75–0.95), 0.93 (95% CI 0.86–0.97), 12.42 (95% CI 6.09–25.31), 0.13 (95% CI 0.06–0.29), and 95.58 (95% CI 35.29–258.89), respectively. Overall, the area under the summary receiver-operating characteristic curve was 0.96 (95% CI 0.94–0.98). Heterogeneity was found to originate potentially from the type of benign lesion. A subgroup analysis showed that differentiating between hemangiomas, cysts, and malignant liver lesions produced a significantly higher diagnostic accuracy than that of solid liver lesions. Conclusion: Our meta-analysis indicated that ADC could be promising for characterizing liver lesions among Asians, indicating that the ADC value is a promising diagnostic criterion candidate. Meanwhile, the use of dual b values could be sufficient for liver lesion characterization. However, large-scale, high-quality trials should be conducted to identify specific standards, including cut-off values for further development of diffusion-weighted imaging as a routine clinical application among Asian populations.
机译:背景:肝癌的患病率和生物学表现出地理和种族差异,这意味着为所有患者制定通用指南是不切实际的。因此,进行了荟萃分析,以识别表观扩散系数(ADC)的准确性,以区分亚洲人良性肝脏病变与恶性肿瘤。方法:发表在PubMed,Ovid和Embase / Medline上的符合条件的研究更新至2014年10月。使用STATA 12.0和Meta-Disc 1.4进行该荟萃分析。结果:包括661例良性肝病变和598例恶性肝病变的八项研究均符合所有纳入标准。合并的敏感性,特异性,阳性似然比,阴性似然比和诊断比值比分别为0.88(95%置信区间[CI] 0.75-0.95),0.93(95%CI 0.86-0.97),12.42(95%CI 6.09- 25.31),0.13(95%CI 0.06-0.29)和95.58(95%CI 35.29-258.89)。总体而言,摘要接收器工作特性曲线下的面积为0.96(95%CI 0.94–0.98)。发现异质性可能源于良性病变的类型。亚组分析表明,与实体肝病变相比,区分血管瘤,囊肿和肝恶性病变的诊断准确性明显更高。结论:我们的荟萃分析表明ADC有望在亚洲人中表征肝脏病变,表明ADC值是有希望的诊断标准候选者。同时,使用双重b值可能足以表征肝脏病变。但是,应该进行大规模,高质量的试验,以确定特定的标准,包括作为进一步发展扩散加权成像作为亚洲人群常规临床应用的临界值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号